When the KDS2010 drug was administered to the spinal cord injury model, it was found that the recovery of the spinal cord tissue in the animal model was accelerated. In the case of the spinal cord injury medication group (SCI/KDS2010), the pain threshold value was significantly increased compared to the non-administration group. This result shows that the level of pain in the animal model is eased when KDS2010 drug is administered to the spinal cord injury model.

The spinal cord injury medication group (SCI/KDS2010) has shown increased spinal tissues and myelination zone compared to the non-medication group. And this means that when KDS2010 is administered to the spinal cord injury model, it promotes spinal tissue regeneration in the animal model.